![True or false? Challenges and recent highlights in the development of aspirin prodrugs - ScienceDirect True or false? Challenges and recent highlights in the development of aspirin prodrugs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523420301677-fx1.jpg)
True or false? Challenges and recent highlights in the development of aspirin prodrugs - ScienceDirect
Searching for New NO-Donor Aspirin-like Molecules: A New Class of Nitrooxy-acyl Derivatives of Salicylic Acid | Journal of Medicinal Chemistry
![Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders | IntechOpen Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders | IntechOpen](https://cdnintech.com/media/chapter/72930/1512345123/media/F5.png)
Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders | IntechOpen
![Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin‐Like Molecules that Covalently Inactivate Cyclooxygenase‐1 - Cena - 2011 - ChemMedChem - Wiley Online Library Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin‐Like Molecules that Covalently Inactivate Cyclooxygenase‐1 - Cena - 2011 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/fb038437-b325-4dc0-b8ac-c1b4b9dce9a5/mcontent.gif)
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin‐Like Molecules that Covalently Inactivate Cyclooxygenase‐1 - Cena - 2011 - ChemMedChem - Wiley Online Library
![Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups | Journal of Medicinal Chemistry Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm900561s/asset/images/medium/jm-2009-00561s_0009.gif)
Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups | Journal of Medicinal Chemistry
![Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders | IntechOpen Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders | IntechOpen](https://cdnintech.com/media/chapter/72930/1512345123/media/F3.png)
Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders | IntechOpen
![EP0170090B1 - substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, intermediates thereto, and processes - Google Patents EP0170090B1 - substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, intermediates thereto, and processes - Google Patents](https://patentimages.storage.googleapis.com/38/e4/83/f53f408b970933/imgb0027.png)
EP0170090B1 - substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, intermediates thereto, and processes - Google Patents
![Molecules | Free Full-Text | Tandem Transesterification–Esterification Reactions Using a Hydrophilic Sulfonated Silica Catalyst for the Synthesis of Wintergreen Oil from Acetylsalicylic Acid Promoted by Microwave Irradiation Molecules | Free Full-Text | Tandem Transesterification–Esterification Reactions Using a Hydrophilic Sulfonated Silica Catalyst for the Synthesis of Wintergreen Oil from Acetylsalicylic Acid Promoted by Microwave Irradiation](https://pub.mdpi-res.com/molecules/molecules-27-04767/article_deploy/html/images/molecules-27-04767-ag.png?1658816544)